Cutting-edge advances are reshaping biotech discovery and diagnostics. David Baker's lab applies AI to understand elusive proteins, revealing new therapeutic targets. Concurrently, quantum computing is gaining traction for solving complex biopharma problems. The Medical University of Vienna secured €2.5M for multiomic biomarker research, enabling high-throughput cellular analyses and spatial tissue insights. Such technological convergence promises to accelerate precision medicine breakthroughs across conditions.